E-slide Library

Colorectal cancer surveillance in Crohn's disease: When and how?

Stephen B. Hanauer, MD

Clifford Joseph Barborka Professor of Medicine
Northwestern University Feinberg School of Medicine
Medical Director, Digestive Health Center
Chicago, IL



People with Crohn's disease may have a higher risk of developing colorectal cancer than the general population. This practice pointer discusses colorectal cancer associated with Crohn's disease and specifically addresses the incidence, risk factors, and recommendations regarding colorectal cancer surveillance.

This activity has been designed to meet the educational needs of gastroenterologists and registered nurses involved in the care of patients with inflammatory bowel disease (IBD).

Release date: January 31, 2015

Learning objectives

After completing this activity, the participant should be better able to:

  • Identify risk factors associated with colorectal cancer in Crohn's disease
  • Evaluate data regarding incidence of colorectal cancer in Crohn's disease
  • Discuss data and recommendations regarding colorectal cancer surveillance in Crohn's disease
  • Provide appropriate care and counsel for patients and their families.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

View Presentation